Medically reviewed by Aleesha Grier, PsyD Seasonal affective disorder (SAD) is sometimes called the "winter blues" because it ...

Intra-Cellular submits an sNDA to the FDA, seeking the label expansion of Caplyta to treat MDD in adults as an adjunctive ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

Psychotherapy focused on healing trauma can be helpful in bringing forgiveness for your past, peace in your present, and hope ...

Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...

The Bipolar Disorder Drugs and Treatment Market is projected to grow at a CAGR of 2.72%, reaching USD 5.8 billion by 2033.

Despite a well-established efficacy, Indiana clinicians are still unwilling to prescribe medications for opioid use disorder to adolescents.

Self-appointed advocates too often prevent the most gravely disabled from accessing care.

Ricki Lake opened up about her ex-husband's death and how he changed her in many ways — including inspiring her to try ...

Edward Scolnick led the development of dozens of medicines while at Merck. His current mission pits him against time and the ...

Leila Nabulsi, PhD, a postdoctoral researcher in computational neuroscience at the Keck School of Medicine of USC's Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) has ...